• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Reproducibility of novel immune-inflammatory biomarkers over 4 months: an analysis with repeated measures design.新型免疫炎症生物标志物在 4 个月内的可重复性:一项重复测量设计的分析。
Biomark Med. 2019 Jun;13(8):639-648. doi: 10.2217/bmm-2018-0351. Epub 2019 Jun 3.
2
CRP and suPAR are differently related to anthropometry and subclinical organ damage.C 反应蛋白和尿可溶性尿激酶型纤溶酶原激活物受体与人体测量学和亚临床器官损伤的关系不同。
Int J Cardiol. 2013 Aug 10;167(3):781-5. doi: 10.1016/j.ijcard.2012.03.040. Epub 2012 Mar 28.
3
Transcriptome profiling of a TGF-beta-induced epithelial-to-mesenchymal transition reveals extracellular clusterin as a target for therapeutic antibodies.TGF-β诱导的上皮-间充质转化的转录组分析揭示细胞外簇蛋白作为治疗性抗体的靶标。
Oncogene. 2010 Feb 11;29(6):831-44. doi: 10.1038/onc.2009.399. Epub 2009 Nov 23.
4
Novel adipokines: methodological utility in human obesity research.新型脂肪因子:在人类肥胖研究中的方法学应用
Int J Obes (Lond). 2017 Jun;41(6):976-981. doi: 10.1038/ijo.2017.68. Epub 2017 Mar 15.
5
Circulating transforming growth factor-β as a prognostic biomarker in Marfan syndrome.循环转化生长因子-β作为马凡综合征的预后生物标志物
Int J Cardiol. 2013 Oct 3;168(3):2441-6. doi: 10.1016/j.ijcard.2013.03.033. Epub 2013 Apr 10.
6
[Expression and correlation of mast cell, Clusterin/apoJ and transforming growth factor-beta in the different stages of human dermal hemangioma].[肥大细胞、簇集素/载脂蛋白J及转化生长因子-β在人皮肤血管瘤不同阶段的表达及相关性]
Hua Xi Kou Qiang Yi Xue Za Zhi. 2009 Aug;27(4):361-5.
7
Plasma clusterin and the risk of Alzheimer disease.血浆簇集素与阿尔茨海默病风险。
JAMA. 2011 Apr 6;305(13):1322-6. doi: 10.1001/jama.2011.381.
8
Transforming growth factor-β and inflammation in vascular (type IV) Ehlers-Danlos syndrome.转化生长因子-β与血管型(IV型)埃勒斯-当洛综合征中的炎症
Circ Cardiovasc Genet. 2014 Feb;7(1):80-8. doi: 10.1161/CIRCGENETICS.113.000280. Epub 2014 Jan 6.
9
The role of human kallikrein 6, clusterin and adiponectin as potential blood biomarkers of dementia.人激肽释放酶6、簇集素和脂联素作为痴呆潜在血液生物标志物的作用。
Clin Biochem. 2016 Feb;49(3):213-8. doi: 10.1016/j.clinbiochem.2015.10.014. Epub 2015 Oct 26.
10
Clusterin expression by astrocytes is influenced by transforming growth factor beta 1 and heterotypic cell interactions.星形胶质细胞的簇集素表达受转化生长因子β1和异型细胞相互作用的影响。
J Neuroimmunol. 1995 Apr;58(1):101-10. doi: 10.1016/0165-5728(94)00194-s.

引用本文的文献

1
Associations between social behaviour and proinflammatory immune activation are modulated by age in a free-ranging primate population.在一个野生灵长类种群中,社交行为与促炎免疫激活之间的关联受到年龄的调节。
Anim Behav. 2025 Jan;219. doi: 10.1016/j.anbehav.2024.10.035. Epub 2024 Dec 14.
2
Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Biomarker of Systemic Chronic Inflammation.可溶性尿激酶型纤溶酶原激活物受体(suPAR)作为全身性慢性炎症的生物标志物。
Front Immunol. 2021 Dec 2;12:780641. doi: 10.3389/fimmu.2021.780641. eCollection 2021.
3
Soluble urokinase plasminogen activator receptor associates with higher risk, advanced disease severity as well as inflammation, and might serve as a prognostic biomarker of severe acute pancreatitis.可溶性尿激酶型纤溶酶原激活物受体与更高的风险、更严重的疾病严重程度以及炎症有关,可能是重症急性胰腺炎的预后生物标志物。
J Clin Lab Anal. 2020 Mar;34(3):e23097. doi: 10.1002/jcla.23097. Epub 2019 Nov 27.

本文引用的文献

1
Healthy lifestyles reduce suPAR and mortality in a Danish general population study.在一项丹麦普通人群研究中,健康的生活方式可降低可溶性尿激酶型纤溶酶原激活物受体(suPAR)水平及死亡率。
Immun Ageing. 2019 Jan 22;16:1. doi: 10.1186/s12979-018-0141-8. eCollection 2019.
2
Soluble urokinase-type plasminogen activator receptor and incident end-stage renal disease in Chinese patients with chronic kidney disease.可溶性尿激酶型纤溶酶原激活物受体与中国慢性肾脏病患者终末期肾病的发生。
Nephrol Dial Transplant. 2020 Mar 1;35(3):465-470. doi: 10.1093/ndt/gfy265.
3
Macrophage migration inhibitory factor promotes cardiac fibroblast proliferation through the Src kinase signaling pathway.巨噬细胞移动抑制因子通过Src 激酶信号通路促进心肌成纤维细胞增殖。
Mol Med Rep. 2018 Feb;17(2):3425-3431. doi: 10.3892/mmr.2017.8261. Epub 2017 Dec 12.
4
Methodological utility of chemerin as a novel biomarker of immunity and metabolism.凯莫瑞作为免疫和代谢新型生物标志物的方法学效用
Endocr Connect. 2017 Jul;6(5):340-347. doi: 10.1530/EC-17-0098. Epub 2017 Jun 7.
5
Novel adipokines: methodological utility in human obesity research.新型脂肪因子:在人类肥胖研究中的方法学应用
Int J Obes (Lond). 2017 Jun;41(6):976-981. doi: 10.1038/ijo.2017.68. Epub 2017 Mar 15.
6
Macrophage Migration Inhibitory Factor is subjected to glucose modification and oxidation in Alzheimer's Disease.在阿尔茨海默病中,巨噬细胞移动抑制因子会发生葡萄糖修饰和氧化。
Sci Rep. 2017 Feb 23;7:42874. doi: 10.1038/srep42874.
7
[Comparison analysis and applications of the Bland-Altman method: correlation or agreement?].[布兰德-奥特曼方法的比较分析与应用:相关性还是一致性?]
Medwave. 2017 Jan 24;17(1):e6852. doi: 10.5867/medwave.2017.01.6852.
8
Premature aging and immune senescence in HIV-infected children.感染艾滋病毒儿童的早衰与免疫衰老
AIDS. 2016 Jun 1;30(9):1363-73. doi: 10.1097/QAD.0000000000001093.
9
Soluble Urokinase Receptor and Chronic Kidney Disease.可溶性尿激酶受体与慢性肾脏病
N Engl J Med. 2016 Mar 3;374(9):890. doi: 10.1056/NEJMc1515787.
10
Role of Macrophage Migration Inhibitory Factor in Obesity, Insulin Resistance, Type 2 Diabetes, and Associated Hepatic Co-Morbidities: A Comprehensive Review of Human and Rodent Studies.巨噬细胞移动抑制因子在肥胖、胰岛素抵抗、2型糖尿病及相关肝脏合并症中的作用:对人类和啮齿动物研究的综合综述
Front Immunol. 2015 Jun 15;6:308. doi: 10.3389/fimmu.2015.00308. eCollection 2015.

新型免疫炎症生物标志物在 4 个月内的可重复性:一项重复测量设计的分析。

Reproducibility of novel immune-inflammatory biomarkers over 4 months: an analysis with repeated measures design.

机构信息

Senior Scientist Group Nutrition, Immunity & Metabolism, Department of Nutrition & Gerontology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.

Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.

出版信息

Biomark Med. 2019 Jun;13(8):639-648. doi: 10.2217/bmm-2018-0351. Epub 2019 Jun 3.

DOI:10.2217/bmm-2018-0351
PMID:31157547
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6630486/
Abstract

Assessment of the feasibility and reliability of immune-inflammatory biomarker measurements. The following biomarkers were assessed in 207 predominantly healthy participants at baseline and after 4 months: MMF, TGF-β, suPAR and clusterin. Intraclass correlation coefficients (95% CIs) ranged from good for TGF-β (0.75 [95% CI: 0.33-0.90]) to excellent for MMF (0.81 [95% CI: 0.64-0.90]), clusterin (0.83 [95% CI: 0.78-0.87]) and suPAR (0.91 [95% CI: 0.88-0.93]). Measurement of TGF-β was challenged by the large number of values below the detection limit. Single measurements of suPAR, clusterin and MMF could serve as feasible and reliable biomarkers of immune-inflammatory pathways in biomedical research.

摘要

评估免疫炎症生物标志物测量的可行性和可靠性。在 207 名主要健康参与者的基线和 4 个月后,评估了以下生物标志物:MMF、TGF-β、suPAR 和 clusterin。内类相关系数(95%置信区间)范围从 TGF-β 的良好(0.75 [95% CI:0.33-0.90])到 MMF 的优秀(0.81 [95% CI:0.64-0.90])、clusterin(0.83 [95% CI:0.78-0.87])和 suPAR(0.91 [95% CI:0.88-0.93])。由于大量值低于检测限,TGF-β 的测量受到了挑战。suPAR、clusterin 和 MMF 的单次测量可以作为生物医学研究中免疫炎症途径的可行和可靠的生物标志物。